Stated Preference Approach in Shaping Urban Sustainable Multimodal Transport—A Literature Review
Systems · 28.09.2025 · 13 (10) · 853
DOI: 10.3390/systems13100853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Systems, online erschienen am 28.09.2025. Verfasst von Nikola Kožul und 3 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Stated preference surveys have been utilized in the field of sustainable multimodal transport planning for some time. Stated preference, which relies on hypothetical scenarios to determine user preferences, offers critical insights into travelers’ choices between different transport modes. The stated preference method is used in a wide range of transport studies, such as the mode choice, route choice, service attribute analysis, pricing and fare policies, and technical innovations. On the basis of the collected data in stated preference studies, it is possible to optimize current services, forecast future demand, or analyze the possibilities of nonexistent services. A literature review reveals that there are certain gaps regarding the calibration of utility functions in multimodal and new services.
Zitieren
APA
Kožul, N., Novačko, L., Babojelić, K., & Brlek, P. (2025). Stated Preference Approach in Shaping Urban Sustainable Multimodal Transport—A Literature Review. Systems, 13(10), 853. https://doi.org/10.3390/systems13100853
Vancouver
Kožul N, Novačko L, Babojelić K, Brlek P. Stated Preference Approach in Shaping Urban Sustainable Multimodal Transport—A Literature Review. Systems. 2025;13(10):853. doi:10.3390/systems13100853
BibTeX
@article{Koul2025,
author = {Kožul, Nikola and Novačko, Luka and Babojelić, Karlo and Brlek, Predrag},
title = {Stated Preference Approach in Shaping Urban Sustainable Multimodal Transport—A Literature Review},
journal = {Systems},
year = {2025},
volume = {13},
number = {10},
pages = {853},
doi = {10.3390/systems13100853}
}
EUVIMED